Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Author:

Van der Weijst Lotte,Aguado-Barrera Miguel E.,Azria David,Berkovic Patrick,Boisselier Pierre,Briers Erik,Bultijnck Renée,Calvo-Crespo Patricia,Chang-Claude Jenny,Choudhury Ananya,Defraene Gilles,Demontois Sylvian,Dunning Alison M.,Elliott Rebecca M.,Ennis Dawn,Faivre-Finn Corinne,Franceschini Marzia,Gutiérrez-Enríquez Sara,Herskind Carsten,Higginson Daniel S.,Kerns Sarah L.,Johnson Kerstie,Mollà Meritxell,Lambrecht Maarten,Ramos Mónica,Rancati Tiziana,Rimner Andreas,Rosenstein Barry S.,De Ruysscher Dirk,Salem Ahmed,Sangalli Claudia,Seibold Petra,Sosa-Fajardo Paloma,Sperk Elena,Stobart Hilary,Summersgill Holly,Surmont Veerle,Symonds Paul,Taboada-Lorenzo Begoña,Talbot Christopher J.,Valdagni Riccardo,Vega Ana,Veldeman Liv,Veldwijk Marlon R.,Ward Tim,Webb Adam,West Catharine M.L.,Lievens Yolande

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3